1 |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2021, 71(3): 209-249.
|
2 |
Bruix J, Sherman M, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update [J]. Hepatology, 2011, 53(3): 1020-1022.
|
3 |
Guang Y, Xie L, Ding H, et al. Diagnosis value of focal liver lesions with SonoVue(R)-enhanced ultrasound compared with contrast-enhanced computed tomography and contrast-enhanced MRI: a meta-analysis [J]. J Cancer Res Clin Oncol, 2011, 137(11): 1595-1605.
|
4 |
Zhang XY, Luo Y, Wen TF, et al. Contrast-enhanced ultrasound: Improving the preoperative staging of hepatocellular carcinoma and guiding individual treatment [J]. World J Gastroenterol, 2014, 20(35): 12628-12636.
|
5 |
Lee YJ, Lee JM, Lee JS, et al. Hepatocellular carcinoma: diagnostic performance of multidetector CT and MR imaging—a systematic review and meta-analysis [J]. Radiology, 2015, 275(1): 97-109.
|
6 |
Di Martino M, Marin D, Guerrisi A, et al. Intraindividual comparison of gadoxetate disodium–enhanced MR imaging and 64-section multidetector CT in the detection of hepatocellular carcinoma in patients with cirrhosis [J]. Radiology, 2010, 256(3): 806-816.
|
7 |
Guo J, Seo Y, Ren S, et al. Diagnostic performance of contrast-enhanced multidetector computed tomography and gadoxetic acid disodium-enhanced magnetic resonance imaging in detecting hepatocellular carcinoma: direct comparison and a metaanalysis [J]. Abdom Radiol (NY), 2016, 41(10): 1960-1972.
|
8 |
American College of Radiology. CEUS Liver Imaging Reporting and Data System Version 2018 [EB/OL]. Accessed May 25 2022.
|
9 |
American College of Radiology. CT/MRI Liver Imaging Reporting and Data System Version 2018 [EB/OL]. Accessed May 25 2022.
|
10 |
Ding J, Long L, Zhang X, et al. Contrast-enhanced ultrasound LI-RADS 2017: comparison with CT/MRI LI-RADS [J]. Eur Radiol, 2021, 31(2): 847-854.
|
11 |
Schellhaas B, Hammon M, Strobel D, et al. Interobserver and intermodality agreement of standardized algorithms for non-invasive diagnosis of hepatocellular carcinoma in high-risk patients: CEUS-LI-RADS versus MRI-LI-RADS [J]. Eur Radiol, 2018, 28(10): 4254-4264.
|
12 |
Wilson SR, Lyshchik A, Piscaglia F, et al. CEUS LI-RADS: algorithm, implementation, and key differences from CT/MRI [J]. Abdom Radiol (NY), 2018, 43(1): 127-142.
|
13 |
Kim TK, Noh SY, Wilson SR, et al. Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017-a review of important differences compared to the CT/MRI system [J]. Clin Mol Hepatol, 2017, 23(4): 280-289.
|
14 |
Kim BR, Lee JM, Lee DH, et al. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging versus multidetector CT in the detection of dysplastic nodules and early hepatocellular carcinoma [J]. Radiology, 2017, 285(1): 134-146.
|
15 |
Kang JH, Choi SH, Lee JS, et al. Interreader agreement of liver imaging reporting and data system on MRI: a systematic review and meta-analysis [J]. J Magn Reson Imaging, 2020, 52(3): 795-804.
|
16 |
Huang JY, Li JW, Lu Q, et al. Diagnostic accuracy of CEUS LI-RADS for the characterization of liver nodules 20 mm or smaller in patients at risk for hepatocellular carcinoma [J]. Radiology, 2020, 294(2): 329-339.
|
17 |
Clarke CGD, Albazaz R, Smith CR, et al. Comparison of LI-RADS with other non-invasive liver MRI criteria and radiological opinion for diagnosing hepatocellular carcinoma in cirrhotic livers using gadoxetic acid with histopathological explant correlation [J]. Clin Radiol, 2021, 76(5): 333-341.
|
18 |
Kim YY, An C, Kim S, et al. Diagnostic accuracy of prospective application of the Liver Imaging Reporting and Data System (LI-RADS) in gadoxetate-enhanced MRI [J]. Eur Radiol, 2018, 28(5): 2038-2046.
|
19 |
Min JH, Kim JM, Kim YK, et al. EASL versus LI-RADS: Intra-individual comparison of MRI with extracellular contrast and gadoxetic acid for diagnosis of small HCC [J]. Liver Int, 2021, 41(12): 2986-2996.
|
20 |
Min JH, Kim JM, Kim YK, et al. Prospective intraindividual comparison of magnetic resonance imaging with gadoxetic acid and extracellular contrast for diagnosis of hepatocellular carcinomas using the liver imaging reporting and data system [J]. Hepatology, 2018, 68(6): 2254-2266.
|
21 |
Kim YY, Kim MJ, Kim EH, et al. Hepatocellular carcinoma versus other hepatic malignancy in cirrhosis: performance of LI-RADS version 2018 [J]. Radiology, 2019, 291(1): 72-80.
|
22 |
Joo I, Lee JM, Lee DH, et al. Retrospective validation of a new diagnostic criterion for hepatocellular carcinoma on gadoxetic acid-enhanced MRI: can hypointensity on the hepatobiliary phase be used as an alternative to washout with the aid of ancillary features? [J]. Eur Radiol, 2019, 29(4): 1724-1732.
|